XENE Shares Outstanding History



Below is a table of the XENE shares outstanding history going back to 10/17/2014:

Date XENE Shares Outstanding
10/17/201413.54M
11/30/201414.18M
3/9/201514.22M
5/11/201514.23M
8/7/201514.29M
11/2/201514.38M
3/4/201614.40M
5/6/201614.40M
7/29/201614.43M
10/28/201617.89M
3/3/201717.94M
5/5/201718.00M
7/31/201718.00M
11/3/201718.00M
3/2/201818.00M
5/4/201814.17M
8/3/201819.26M
11/2/201825.24M
3/1/201925.75M
5/3/201925.77M
8/2/201925.78M
8/29/2019236.27M
11/1/201925.87M
3/5/202034.96M
5/18/202034.97M
8/4/202034.99M
11/3/202035.01M
2/26/202135.81M
5/7/202140.97M
8/9/202141.12M
11/8/202151.59M
2/25/202251.92M
8/5/202262.26M
11/4/202262.54M
2/24/202363.04M
5/5/202363.56M
8/4/202364.15M
11/3/202365.43M
2/26/202475.43M

Also see: XENE Market Cap History
XENE YTD Return
XENE Historical Shares Outstanding:
+20.13% CAGR
XENE Historical Shares Outstanding: +20.13% CAGR

Mouse over chart for data details
10/17/2014 ...2/26/2024
Xenon Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing therapeutics for patients with neurological disorders. Co.'s product pipeline of neurology-focused therapies focus on epilepsy. Co.'s product candidates include: XEN1101, a Kv7 potassium channel opener for the treatment of epilepsy and potentially other neurological disorders, such as major depressive disorder; and XEN496, a Kv7 potassium channel opener for the treatment of KCNQ2 developmental and epileptic encephalopathy. In addition, Co. has a license and collaboration agreement with Neurocrine Biosciences Inc. to develop NBI-921352, a Nav1.6 sodium channel inhibitor for the treatment of epilepsy. We show 39 historical shares outstanding datapoints in our coverage of XENE's shares outstanding history.

Understanding the changing numbers of XENE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like XENE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching XENE by allowing them to research XENE shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree XENE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
 

XENE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.